Vertex triple combinations

Drug Overview
Product Profiles
Vertex triple combination program : Cystic fibrosis

Figure 1: Vertex triple combination program for cystic fibrosis – SWOT analysis
Figure 2: The authors drug assessment summary of Vertex triple combination program for cystic fibrosis
Figure 3: The authors drug assessment summary of Vertex triple combination program for cystic fibrosis
Figure 4: Vertex triple combination program sales for cystic fibrosis across the US and five major EU markets, by country, 2016–25

Table 1: Vertex triple combination program drug profile
Table 2: Vertex triple combination program Phase II data in cystic fibrosis
Table 3: Vertex triple combination program Phase III data in cystic fibrosis
Table 4: Vertex triple combination program sales for cystic fibrosis across the US and five major EU markets, by country ($m), 2016–25